“Smaller manufacturers will need to invest in upgraded facilities… Yet, these changes are necessary to reduce operational risks, minimize recalls and ensure consistent product quality,” said Parag Bhatia, director of Laborate Pharmaceuticals, a maker of generic medicines in Panipat, Haryana. The concern remains, however, whether the large number of small units in India have the wherewithal, both financial and technical, to do so, he added.
India sets 2026 health agenda: Drug quality, innovation, TB and obesity take centre stage
Date:
More like thisRelated
Ministry of Tourism, Air India sign MoU to promote India as a global tourism destination
The Ministry of Tourism has signed a Memorandum of...
Market Pulse: Key triggers to watch before the July 24 trading session
Indian markets and investors will closely track developments in...
Brent crude crosses $100 as Red Sea attacks stoke fears of supply disruptions
Crude futures surged nearly 6% in the domestic market...
Wall Street ends mixed as investors focus on tech earnings
* निवेशकों को एआई दिग्गजों से कमाई का इंतजार...